Skip to main content

Table 4 Results of ovarian cancer survival analysis for the KLK15 rs266851 SNP in Australian, UK GWAS data, TCGA data and the combined datasets

From: A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival

KLK15rs266851

n

n censored

Adjusted* HR (95% CI)*

Australian

   

CC

222

128

1.0

CT/TT

96

60

1.42 (1.02-1.96)

UK GWAS**

   

CC

1139

390

1.0

CT/TT

676

221

1.07 (0.94-1.24)

TCGA***

   

CC

280

135

1.0

CT/TT

133

76

1.20 (0.90-1.61)

Combined Analysis

   

CC

1641

653

1.0

CT/TT

905

357

1.16 (1.00-1.34)

  1. *Adjusted for age, FIGO stage, histological subtype, and grade.
  2. **The UK GWAS dataset was adjusted for age, FIGO stage, histologic subtype, grade and study site.
  3. ***The TCGA dataset was adjusted for age, FIGO stage and histologic grade, but not subtype as all the samples were of the serous subtype.